Teachers Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.77M Buy
129,992
+1,248
+1% +$16.2K ﹤0.01% 2022
2018
Q4
$1.32M Buy
128,744
+8,701
+7% +$111K ﹤0.01% 2065
2018
Q3
$2M Buy
120,043
+4,174
+4% +$75.4K ﹤0.01% 1980
2018
Q2
$1.83M Sell
115,869
-3,541
-3% -$53.8K ﹤0.01% 1998
2018
Q1
$1.52M Sell
119,410
-1,521
-1% -$22K ﹤0.01% 2007
2017
Q4
$1.39M Buy
120,931
+26,233
+28% +$293K ﹤0.01% 2060
2017
Q3
$1.16M Buy
94,698
+9,993
+12% +$104K ﹤0.01% 2149
2017
Q2
$970K Buy
84,705
+3,091
+4% +$57.1K ﹤0.01% 2250
2017
Q1
$1.7M Buy
81,614
+4,805
+6% +$106K ﹤0.01% 1860
2016
Q4
$1.6M Buy
76,809
+1,171
+2% +$30.4K ﹤0.01% 1920
2016
Q3
$2.48M Buy
75,638
+967
+1% +$29.4K ﹤0.01% 1588
2016
Q2
$1.86M Buy
74,671
+39,876
+115% +$1.08M ﹤0.01% 1700
2016
Q1
$852K Sell
34,795
-78,750
-69% -$1.82M ﹤0.01% 2060
2015
Q4
$3.75M Sell
113,545
-32,660
-22% -$1.1M 0.01% 1249
2015
Q3
$4.79M Sell
146,205
-25,717
-15% -$1.09M 0.01% 1136
2015
Q2
$9.11M Buy
171,922
+43,580
+34% +$1.59M 0.02% 940
2015
Q1
$3.7M Buy
128,342
+116,924
+1,024% +$3.21M 0.01% 1293
2014
Q4
$332K Hold
11,418
﹤0.01% 2666
2014
Q3
$145K Hold
11,418
﹤0.01% 2984
2014
Q2
$229K Buy
+11,418
New +$161K ﹤0.01% 2876

Other funds holding ALDR

Teachers Advisors's ALDR Position: Q1 2019 in Review

Teachers Advisors increased its Alder Biopharmaceuticals (ALDR) stake by 0.97% in Q1 2019, buying an estimated $16.2K and bringing the position to 129,992 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Teachers Advisors first reported a position in ALDR in Q2 2014 and has held it in 20 quarters since. The position peaked at $9.11M in Q2 2015. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

  • Teachers Advisors held 129,992 shares of Alder Biopharmaceuticals worth $1.77M as of Q1 2019.
  • Teachers Advisors bought 1,248 Alder Biopharmaceuticals shares in Q1 2019, an estimated $16.2K.
  • Alder Biopharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2022 holding.
  • Teachers Advisors first reported a position in Alder Biopharmaceuticals in Q2 2014 and has held it in 20 quarters since.
  • Teachers Advisors's Alder Biopharmaceuticals position peaked at $9.11M in Q2 2015.
  • 123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.